GlassScriptPhysician profile
Gregory Scott Tracy
NPI 1154715159
$1,008.10
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
See the full distribution for Adolescent Medicine (Pediatrics)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $183 · 2020: $91.19 · 2022: $199 · 2023: $471 · 2024: $63.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $535.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $534.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $253.55 | 2022-2024 | Azstarys |
| Ironshore Pharmaceuticals INC. | $229.90 | 2019-2023 | Jornay Pm |
| Glaxosmithkline, LLC. | $130.47 | 2019-2024 | Bexsero, Pediarix, Menveo |
| Tris Pharma INC | $93.80 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $56.57 | 2022-2023 | Qelbree |
| Merck Sharp & Dohme LLC | $51.02 | 2020-2023 | Vaxneuvance, Gardasil 9, M-M-R II |
| Pfizer INC. | $47.77 | 2019-2023 | |
| Neos Therapeutics, LP | $30.60 | 2020-2023 | Adzenys Xr-Odt |
| Novo Nordisk INC | $22.69 | 2024 | |
| Seqirus USA INC | $20.59 | 2023 | Flucelvax Quadrivalent |
| Phadia US INC. | $18.52 | 2023 | Immunocap |
| Shire North American Group INC | $15.30 | 2019 | |
| Kaleo, INC. | $13.19 | 2019 | |
| Sobi, INC | $13.16 | 2019 | |
| Genentech USA, INC. | $10.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Tracy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.